SAN FRANCISCO, CA AND NEW YORK, NY / ACCESS Newswire / February 24, 2026 / Unlearn, a leading artificial intelligence company in the clinical development space, today announced its use of data from ...

Unlearn seems to have retained a lesson or two about fundraising: The digital twin developer announced this week that it has raised another $50 million, echoing its last funding round two years ago.

AI-powered digital twins help interpret early signals in a small Phase 2a study of a novel therapy for Alzheimer’s Disease SAN FRANCISCO & LEUVEN, Belgium, April 03, 2025--(BUSINESS WIRE)--Unlearn®, a ...

Unlearn and Merck KGaA have announced a partnership to accelerate drug trials using medical digital twins of patients. Unlearn uses recent developments from deep learning to create digital twins of ...

Patient-level digital twins expected to strengthen evidence generation in Phase1/2 clinical study evaluating VTx-002, a first-in-class vectorized antibody targeting TDP-43 pathology in patients with a ...

Throughout the history of medicine, drug developers have tried to make clinical trials faster and more efficient. Artificial intelligence and machine-learning methods are some of the newer approaches ...

Leading well in a complex environment requires more than adding new skills. To grow your capacity in uncertain moments, you need to unlearn the habits that limit how you show up. Start with these ...